Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 65%
Date: 20-05-2026
Price: $2.060
Last Price: $2.050
TEL AVIV, Israel and RALEIGH, NC, March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will present at the following upcoming virtual conferences in March: RedHill Biopharma Sachs Spring Life
TEL AVIV, Israel and RALEIGH, NC, March 2, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering a
Following review of data from the U.S. Phase 2 study by the FDA, RedHill plans to expand the global Phase 2/3 study of orally-administered opaganib for severe COVID-19 to the U.S. The study has enrolled over 50% of the targeted 464 patients globally; U.S. study activities expected to expand the stu
Chart available once enough post-signal price data is available.
AI Confidence - 65 % model confidence
Gryphon Capital Income Trust is an Australian investment trust focused on providing investors with exposure to a diversified portfolio of Australian small and mid-cap companies. It aims to generate income and capital growth through active management and selective investments in undervalued or high-potential businesses within the Australian equity market.
| Cash Flow | Unknown |
| Debt | Unknown |
| Profitability | Unknown |
| Revenue Trend | Unknown |
| Trend | Bullish |
| Momentum | Moderate |
| RSI Signal | Neutral |
| Support Level | $ 2.00 |
| Resistance Level | $ 2.15 |